Ovation Science Inc. (CSE:OVAT)

Canada · Delayed Price · Currency is CAD

0.0350

0.00 (0.00%)

Feb 25, 2026, 2:01 PM EST

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Biotechnology (Startups)	113.22K	61.93K	138.15K	224.95K	750.01K
Biotechnology (Startups) Growth	82.80%	-55.17%	-38.58%	-70.01%	148.03%
Total	113.22K	61.93K	138.15K	224.95K	750.01K
Total Growth	82.80%	-55.17%	-38.58%	-70.01%	148.03%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Canada	-	33.74K	1.21K	43.12K	750.01K
Canada Growth	-	2690.90%	-97.20%	-94.25%	148.03%
United States	113.22K	28.19K	136.95K	146.65K	-
United States Growth	301.59%	-79.41%	-6.62%	-	-
Mexico	-	-	-	35.18K	-
Total	113.22K	61.93K	138.15K	224.95K	750.01K
Total Growth	82.80%	-55.17%	-38.58%	-70.01%	148.03%

Source: S&P Global Market Intelligence.